-
SPRY Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
ARS Pharmaceuticals (SPRY)
Company Profile
Quarter (USD) | Sep 24 | Mar 24 | Dec 23 | Sep 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 39.66 mm | 39.66 mm | 39.66 mm | 39.66 mm | 39.66 mm | |
Cash burn (monthly) | 5.45 mm | 6.61 mm | 7.25 mm | 5.26 mm | 3.07 mm | |
Cash used (since last report) | 15.21 mm | 18.46 mm | 20.23 mm | 14.69 mm | 8.58 mm | |
Cash remaining | 24.45 mm | 21.20 mm | 19.42 mm | 24.97 mm | 31.08 mm | |
Runway (months of cash) | 4.5 | 3.2 | 2.7 | 4.7 | 10.1 |
13F holders | Current |
---|---|
Total holders | 71 |
Opened positions | 31 |
Closed positions | 60 |
Increased positions | 19 |
Reduced positions | 11 |
13F shares | Current |
---|---|
Total value | 373.40 bn |
Total shares | 62.37 mm |
Total puts | 83.80 k |
Total calls | 2.30 mm |
Total put/call ratio | 0.0 |
Largest owners | Shares | Value |
---|---|---|
Deerfield Management | 11.08 mm | $94.27 bn |
Flynn James E | 11.08 mm | $0.00 |
Ra Capital Management | 10.86 mm | $92.43 bn |
Orbimed Advisors | 9.24 mm | $78.64 bn |
Pratik Shah Living Trust dated June 15, 2011 | 5.22 mm | $46.66 mm |
BEN Franklin Resources | 2.95 mm | $25.11 bn |
K2 Principal Fund | 2.46 mm | $20.95 bn |
Nextech Vi Oncology SCSP | 1.91 mm | $0.00 |
Nextech Invest | 1.91 mm | $16.25 bn |
STT State Street | 1.86 mm | $15.80 bn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
17 Dec 24 | Sarina Tanimoto | Common Stock | Sell | Dispose S | Yes | Yes | 11.6705 | 50,000 | 583.53 k | 1,098,499 |
17 Dec 24 | Sarina Tanimoto | Common Stock | Sell | Dispose S | Yes | Yes | 11.6715 | 50,000 | 583.58 k | 1,297,447 |
17 Dec 24 | Richard E Lowenthal | Common Stock | Sell | Dispose S | Yes | Yes | 11.6705 | 50,000 | 583.53 k | 1,098,499 |
17 Dec 24 | Richard E Lowenthal | Common Stock | Sell | Dispose S | Yes | Yes | 11.6715 | 50,000 | 583.58 k | 1,297,447 |
13 Dec 24 | Justin Chakma | Common Stock | Sell | Dispose S | No | No | 12.0625 | 27,272 | 328.97 k | 136,380 |
13 Dec 24 | Justin Chakma | Common Stock | Option exercise | Acquire M | No | No | 1.44 | 27,272 | 39.27 k | 163,652 |
13 Dec 24 | Justin Chakma | Stock Option Common Stock | Option exercise | Dispose M | No | No | 1.44 | 27,272 | 39.27 k | 55,461 |
12 Dec 24 | Justin Chakma | Common Stock | Sell | Dispose S | No | No | 12.2653 | 117,333 | 1.44 mm | 136,380 |
12 Dec 24 | Justin Chakma | Common Stock | Option exercise | Acquire M | No | No | 0.84 | 117,333 | 98.56 k | 253,713 |
12 Dec 24 | Justin Chakma | Stock Option Common Stock | Option exercise | Dispose M | No | No | 0.84 | 117,333 | 98.56 k | 119,047 |